Enhanced anti-tumor activity and cytotoxic effect on cancer stem cell population of metformin-butyrate compared with metformin HCl in breast cancer

Metformin, which is a drug commonly used to treat type 2 diabetes, has shown anti-tumor effects in numerous experimental, epidemiologic, observational, and clinical studies. Here, we report a new metformin derivative, metformin-butyrate (MFB). Compared to metformin-HCl, it more potently activates AM...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kyung-Min, Lee, Minju, Lee, Jiwoo, Kim, Sung Wuk, Moon, Hyeong-Gon, Noh, Dong-Young, Han, Wonshik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122406/
https://www.ncbi.nlm.nih.gov/pubmed/27223262
http://dx.doi.org/10.18632/oncotarget.9522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122406/
https://www.ncbi.nlm.nih.gov/pubmed/27223262
http://dx.doi.org/10.18632/oncotarget.9522

Ejemplares similares